GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sphere Medical Holding PLC (LSE:SPHR) » Definitions » Days Sales Outstanding

Sphere Medical Holding (LSE:SPHR) Days Sales Outstanding : 182.50 (As of Dec. 2016)


View and export this data going back to 2011. Start your Free Trial

What is Sphere Medical Holding Days Sales Outstanding?

Sphere Medical Holding's average Accounts Receivable for the six months ended in Dec. 2016 was £0.02 Mil. Sphere Medical Holding's Revenue for the six months ended in Dec. 2016 was £0.02 Mil. Hence, Sphere Medical Holding's Days Sales Outstanding for the six months ended in Dec. 2016 was 182.50.

The historical rank and industry rank for Sphere Medical Holding's Days Sales Outstanding or its related term are showing as below:

LSE:SPHR' s Days Sales Outstanding Range Over the Past 10 Years
Min: 30.06   Med: 121.67   Max: 501.88
Current: 292

During the past 9 years, Sphere Medical Holding's highest Days Sales Outstanding was 501.88. The lowest was 30.06. And the median was 121.67.

LSE:SPHR's Days Sales Outstanding is not ranked
in the Medical Devices & Instruments industry.
Industry Median: 64.88 vs LSE:SPHR: 292.00

Sphere Medical Holding's Days Sales Outstanding stayed the same from Dec. 2015 (182.50) to Dec. 2016 (182.50).

Warning Sign:

If a company sales outstanding increases, it means it has difficulty collecting payment from its customers.


Sphere Medical Holding Days Sales Outstanding Historical Data

The historical data trend for Sphere Medical Holding's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sphere Medical Holding Days Sales Outstanding Chart

Sphere Medical Holding Annual Data
Trend Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16
Days Sales Outstanding
Get a 7-Day Free Trial Premium Member Only 380.87 209.88 117.32 109.50 176.42

Sphere Medical Holding Semi-Annual Data
Dec11 Jun12 Dec12 Jun13 Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 121.67 73.00 182.50 152.08 182.50

Competitive Comparison of Sphere Medical Holding's Days Sales Outstanding

For the Medical Devices subindustry, Sphere Medical Holding's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sphere Medical Holding's Days Sales Outstanding Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Sphere Medical Holding's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Sphere Medical Holding's Days Sales Outstanding falls into.



Sphere Medical Holding Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Sphere Medical Holding's Days Sales Outstanding for the fiscal year that ended in Dec. 2016 is calculated as

Days Sales Outstanding (A: Dec. 2016 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2015 ) + Accounts Receivable (A: Dec. 2016 )) / count ) / Revenue (A: Dec. 2016 )*Days in Period
=( (0.005 + 0.024) / 2 ) / 0.03*365
=0.0145 / 0.03*365
=176.42

Sphere Medical Holding's Days Sales Outstanding for the quarter that ended in Dec. 2016 is calculated as:

Days Sales Outstanding (Q: Dec. 2016 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Jun. 2016 ) + Accounts Receivable (A: Dec. 2016 )) / count ) / Revenue (A: Dec. 2016 )*Days in Period
=( (0 + 0.024) / 1 ) / 0.024*365 / 2
=0.024 / 0.024*365 / 2
=182.50

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sphere Medical Holding  (LSE:SPHR) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


Sphere Medical Holding Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Sphere Medical Holding's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


Sphere Medical Holding (LSE:SPHR) Business Description

Traded in Other Exchanges
N/A
Address
Harston Mill, Harston, Cambridge, GBR, CB22 7GG
Sphere Medical Holding Ltd is a UK-based company which is engaged in research and development, manufacturing and sale of medical monitoring and diagnostic equipment within the medical device area. It focuses on developing the Proxima platform for measuring blood gases, electrolytes and metabolites. Proxima is an in-line patient dedicated arterial blood analyser which supports frequent measurements at critical times. It markets its product (Proxima) to critical care market which includes ICU (Intensive Care Unit) and OR (Operating Room). The company's products are used in medical applications, enabling faster clinical decision-making and improved patient outcomes. It operates is business in single reporting segment of Medical devices. Most of the company's revenue comes from Europe.